Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
56
Number of overlapping holdings
53.3%
% of BMED's 115 holdings also in IBBQ
25.5%
% of IBBQ's 220 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 8.1% | 3.7% |
 |
ARGENX SE ADR | 3.3% | 1.9% | 1.9% |
|
AMGEN INC | 1.3% | 8.2% | 1.3% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 1.2% | 1.2% |
|
BEIGENE LTD. SPONSORED ADR | 1.4% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to IBBQ
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
REPLIGEN CORP | 2.1% |
BMED Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -8.2% |
|
REGENERON PHARMACEUTICALS | -7.1% |
|
AMGEN INC | -7.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.4% |
|
GILEAD SCIENCES INC | -4.4% |
|
ALNYLAM PHARMACEUTICALS INC | -2.6% |
|
SUMMIT THERAPEUTICS INC | -1.5% |
|
INTRA-CELLULAR THERAPIES INC | -1.4% |
|
BIOMARIN PHARMACEUTICAL INC | -1.4% |
|
ROYALTY PHARMA PLC CLASS A | -1.4% |